Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack
J Li, J Liu, M Liu, S Zhang, Z Hao… - Cochrane Database …, 2015 - cochranelibrary.com
Background The optimal therapy for preventing recurrent stroke in people with cryptogenic
stroke and patent foramen ovale (PFO) has not been defined. The choice between medical …
stroke and patent foramen ovale (PFO) has not been defined. The choice between medical …
Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack.
J Li, J Liu, M Liu, S Zhang, Z Hao, J Zhang… - … Cochrane Database of …, 2015 - europepmc.org
Background The optimal therapy for preventing recurrent stroke in people with cryptogenic
stroke and patent foramen ovale (PFO) has not been defined. The choice between medical …
stroke and patent foramen ovale (PFO) has not been defined. The choice between medical …
Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack
J Li, J Liu, M Liu, S Zhang, Z Hao… - The Cochrane …, 2015 - pubmed.ncbi.nlm.nih.gov
Background The optimal therapy for preventing recurrent stroke in people with cryptogenic
stroke and patent foramen ovale (PFO) has not been defined. The choice between medical …
stroke and patent foramen ovale (PFO) has not been defined. The choice between medical …
Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack
J Li, J Liu, M Liu, S Zhang, Z Hao… - Cochrane Database …, 1996 - cochranelibrary.com
Background The optimal therapy for preventing recurrent stroke in people with cryptogenic
stroke and patent foramen ovale (PFO) has not been defined. The choice between medical …
stroke and patent foramen ovale (PFO) has not been defined. The choice between medical …
[HTML][HTML] Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic …
J Li, J Liu, M Liu, S Zhang, Z Hao, J Zhang… - … Cochrane Database of …, 2015 - ncbi.nlm.nih.gov
Background The optimal therapy for preventing recurrent stroke in people with cryptogenic
stroke and patent foramen ovale (PFO) has not been defined. The choice between medical …
stroke and patent foramen ovale (PFO) has not been defined. The choice between medical …